DEEPIKA PAKIANATHAN - 22 Aug 2024 Form 4 Insider Report for Mereo BioPharma Group plc (MREO)

Role
Director
Signature
/s/ Deepika Pakianathan
Issuer symbol
MREO
Transactions as of
22 Aug 2024
Net transactions value
-$315,094
Form type
4
Filing time
23 Aug 2024, 18:13:05 UTC
Previous filing
07 Jun 2024
Next filing
06 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MREO American Depositary Shares representing Ordinary Shares Options Exercise $5,475 +1,825 $3.00 1,825 22 Aug 2024 Direct F1
transaction MREO American Depositary Shares representing Ordinary Shares Options Exercise $11,945 +6,492 +356% $1.84 8,317 22 Aug 2024 Direct F1
transaction MREO American Depositary Shares representing Ordinary Shares Options Exercise $33,777 +12,418 +149% $2.72 20,735 22 Aug 2024 Direct F1
transaction MREO American Depositary Shares representing Ordinary Shares Options Exercise $51,028 +38,953 +188% $1.31 59,688 22 Aug 2024 Direct F1
transaction MREO American Depositary Shares representing Ordinary Shares Options Exercise $40,876 +43,485 +73% $0.9400 103,173 22 Aug 2024 Direct F1
transaction MREO American Depositary Shares representing Ordinary Shares Options Exercise $8,015 +2,071 +2% $3.87 105,244 22 Aug 2024 Direct F1
transaction MREO American Depositary Shares representing Ordinary Shares Sale $466,210 -105,244 -100% $4.43 0 22 Aug 2024 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MREO Share Options (right to buy) Options Exercise $0 -5,500 -100% $0.000000 0 22 Aug 2024 American Depository Shares 5,500 $3.00 Direct F1, F4
transaction MREO Share Options (right to buy) Options Exercise $0 -11,000 -100% $0.000000 0 22 Aug 2024 American Depository Shares 11,000 $1.84 Direct F1, F5
transaction MREO Share Options (right to buy) Options Exercise $0 -31,500 -100% $0.000000 0 22 Aug 2024 American Depository Shares 31,500 $2.72 Direct F1, F6
transaction MREO Share Options (right to buy) Options Exercise $0 -55,000 -100% $0.000000 0 22 Aug 2024 American Depository Shares 55,000 $1.31 Direct F1, F7
transaction MREO Share Options (right to buy) Options Exercise $0 -55,000 -100% $0.000000 0 22 Aug 2024 American Depository Shares 55,000 $0.9400 Direct F1, F8
transaction MREO Share Options (right to buy) Options Exercise $0 -15,000 -33% $0.000000 30,000 22 Aug 2024 American Depository Shares 15,000 $3.87 Direct F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share ("ADS") represents five ordinary shares of the Issuer.
F2 Sale is due to fund administration reasons.
F3 The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $4.360 to $4.495, inclusive. The Reporting Person undertakes to provide to Mereo BioPharma Group plc ("Mereo"), any security holder of Mereo, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ADSs sold at each separate price within the ranges set forth in footnote (3) to this Form
F4 Vested in substantially equal monthly installments over a one year period from the July 23, 2019 grant date.
F5 Vested in substantially equal monthly installments over a one year period from the February 20, 2020 grant date.
F6 Vested in substantially equal monthly installments over a one year period from the February 1, 2021 grant date.
F7 Vested in substantially equal monthly installments over a one year period from the February 1, 2022 grant date.
F8 Vested in substantially equal monthly installments over a one year period from the February 1, 2023 grant date.
F9 Vests in substantially equal monthly installments over a one year period from the February 8, 2024 grant date. As of June 8, 2024, 15,000 Share Options have vested.